CORT Stock UPDATES Corcept Therapeutics Inc (CORT) 3.01 10/22/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 22, 2014 at 4:42 AM

Corcept Therapeutics Inc (CORT) 3.01 $CORT

Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:32AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as the company saw its shares rise more than 6% on the day.
CANF: 3.12 (unch), AMPE: 3.70 (-0.30), CEMP: 12.19 (-0.03), CORT: 3.01 (+0.01)

Heartbeat Wins 8 New Awards, Including CLIO Silver & MM&M Gold
Business Wire - Mon Oct 13, 11:01AM CDT
Heartbeat Ideas and Heartbeat West, natively-digital, full-service, marketing innovation agencies, have won eight new awards over the last few weeks, bringing to 16 the total number of industry awards in this record-setting year for the company. Heartbeat's honored work includes Corcept Therapeutics' Korlym "Cushing's Connection" Integrated Campaign, XenoPort's HORIZANT "End the Bedtime Battle" Integrated Campaign, and Sientra's "Feel So Good" Online Media Campaign.
CORT: 3.01 (+0.01)

Esperion Therapeutics Slumps: ESPR Falls 6.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:48AM CDT
Esperion Therapeutics has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ESPR: 22.80 (+0.71), AMPE: 3.70 (-0.30), CEMP: 12.19 (-0.03), CORT: 3.01 (+0.01)

PTC Therapeutics (PTCT) Crumbles: Stock Falls by 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:42AM CDT
PTC Therapeutics stock fell over 5% last trading session, continuing its recent downtrend
LCI: 44.96 (+1.04), PTCT: 37.90 (+0.34), CEMP: 12.19 (-0.03), CORT: 3.01 (+0.01)

Publicis Healthcare Agencies and Leaders Honored at the 2014 MM&M Awards
PRWeb - Mon Oct 06, 7:04AM CDT
Publicis Healthcare Communications Group (PHCG), the world's largest health-oriented communications network, today announced four of its network agencies were honored at the 2014 MM&M Awards, making Publicis Healthcare the most winning agency network recognized. Additionally, Matt McNally, President, Publicis Health Media, received the Silver Agency Marketer of the Year Award, and Allyson Mariani, Media Planner, Publicis Health Media, was honored with the Gold Young Marketer of the Year Award. PHCG agencies picked up nine MM&M awards, including: Agency Marketer of the Year (Silver MM&M Award): Matt McNally, President, Publicis Health Media Young Marketer of the Year (Gold MM&M Award): Allyson Mariani, Media Planner, Publicis Health Media Best Use of Direct Marketing (Gold MM&M Award): Heartbeat West and Sientra for "Feel So Good" Best Use of Direct Marketing (Silver MM&M Award): Digitas Health LifeBrands and Rebif(R) (interferon beta-1a) by EMD Serono, Inc. and Pfizer Inc for "Rebif Information Kit" Best Branded Website for Healthcare Professionals (Gold MM&M Award): Publicis Life Brands Medicus and Chattem, a Sanofi company for "Nasacort Allergy 24HR Launch Website" Best Use of Social Media (Silver MM&M Award): Heartbeat Ideas, Heartbeat West, and Corcept Therapeutics for "Cushing's Connection" Best Medical Digital Initiative for Consumers (Silver MM&M Award): Heartbeat Ideas, Heartbeat West, and Corcept Therapeutics for "Cushing's Connection" Best Philanthropic Campaign (Gold MM&M Award): Saatchi & Saatchi Wellness and Crossroads Community for "Crossroads Community Street Fare" Best TV Advertising Campaign (Gold MM&M Award): Saatchi & Saatchi Wellness and AbbVie (Humira) for "Inside The Circle"
CORT: 3.01 (+0.01)

Cortendo AB to Present at the 14th Annual BIOTECH in Europe Forum in Basel September 30, 2014
Business Wire - Mon Sep 29, 4:54AM CDT
Cortendo AB (OAX:CORT)
CORT: 3.01 (+0.01)

5 Stocks to Trade for Big Breakout Gains
at The Street - Mon Sep 22, 10:45AM CDT
These stocks look ready to break out and trade higher from current levels.
TSLA: 235.34 (+4.87), FLL: 1.27 (-0.01), SYRX: 3.00 (-0.01), GOOGL: 538.03 (+5.65), CORT: 3.01 (+0.01), GSAT: 2.26 (-0.03)

Cortendo AB: Interim Report, Q2 and H1 2014
Business Wire - Tue Aug 26, 2:14AM CDT
Cortendo AB (OSE:CORT)
CORT: 3.01 (+0.01)

Investors look to Lighten Up on Shares of Corcept Therapeutics, Shares Down 8.8% (CORT)
Comtex SmarTrend(R) - Thu Aug 21, 12:42PM CDT
Corcept Therapeutics (NASDAQ:CORT) is one of today's worst performing low-priced stocks, down 8.8% to $2.69 on 1.1x average daily volume. Corcept Therapeutics has traded 248,000 shares thus far today, vs. average volume of 226,000 shares per day. The stock has underperformed the Dow (-8.8% to the Dow's 0.5%) and underperformed the S&P 500 (-8.8% to the S&P's 0.3%) during today's trading.
CORT: 3.01 (+0.01)

Earnings Estimates Moving Higher for Corcept Therapeutics (CORT): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 7:43AM CDT
Corcept Therapeutics could be a solid choice for investors, as it witnessed solid activity on the earnings estimate revision front and also has a favorable Zacks Rank.
CORT: 3.01 (+0.01)

Cortendo AB: First Patient Enrolled into NormoCort Phase 3 SONICS Trial Following a Successful EU Investigator Meeting
Business Wire - Tue Aug 12, 1:30AM CDT
Cortendo AB (OSE:CORT) today announced that the first patient has been enrolled into the Phase 3 SONICS trial, i.e., "Study Of NormoCort In Cushing's Syndrome."
CORT: 3.01 (+0.01)

Cortendo names Matthew Pauls as CEO
M2 - Thu Aug 07, 4:57AM CDT
Biopharmaceutical company Cortendo AB (OSE:CORT) today announced that it has appointed Matthew Pauls as president and chief executive officer, effective 25 August 2014.
INSM: 13.63 (+0.11), CORT: 3.01 (+0.01)

Cortendo Appoints Matthew Pauls as Chief Executive Officer
Business Wire - Thu Aug 07, 2:00AM CDT
Cortendo AB (OSE:CORT) announces the appointment of Matthew Pauls as President and Chief Executive Officer effective Monday, August 25, 2014.
CORT: 3.01 (+0.01)

Corcept Therapeutics Announces Second Quarter 2014 Financial Results and Provides Corporate Update
Marketwire - Tue Aug 05, 3:06PM CDT
Corcept Therapeutics Incorporated (NASDAQ: CORT)
CORT: 3.01 (+0.01)

Corcept Therapeutics to Announce Second Quarter Financial Results and Host Conference Call
Marketwire - Tue Jul 29, 3:07PM CDT
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 5, 2014. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
CORT: 3.01 (+0.01)

Corcept Therapeutics Down 5.4%, Shares Slide into the Red (CORT)
Comtex SmarTrend(R) - Mon Jul 28, 12:43PM CDT
Corcept Therapeutics (NASDAQ:CORT) is one of today's worst performing low-priced stocks, down 5.4% to $2.28 on 1.0x average daily volume. Corcept Therapeutics has traded 296,000 shares thus far today, vs. average volume of 287,000 shares per day. The stock has underperformed the Dow (-5.4% to the Dow's 0.2%) and underperformed the S&P 500 (-5.4% to the S&P's 0.1%) during today's trading.
CORT: 3.01 (+0.01)

/ CORRECTION - Corcept Therapeutics
Marketwire - Fri Jun 20, 3:15PM CDT
In the news release, "New Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014," issued Thursday, June 19, 2014 by Corcept Therapeutics (NASDAQ: CORT), we are advised by the company that the session schedule has now been updated to reflect accurate presentation times with poster numbers added. Complete corrected text follows.
CORT: 3.01 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...